Fertility benefits provider Carrot and digital male fertility clinic Legacy have recently teamed up to better understand what Americans know about sperm. The result is “The 2023 Sperm Report” based on data from nearly 3.000 respondents that reveals knowledge levels and misconceptions around sperm, its role in conception, and how it is impacting fertility. Some highlights:
Kindbody is a technology-driven fertility clinic network and family-building benefits provider for employers offering virtual and in-person care. To support future company growth, the company has raised $100M in capital from Perceptive Advisors, a leading life sciences investment firm, to support future company growth. The latest financing brings Kindbody’s total equity and debt funding to more than $290M, and its valuation to $1.8B, solidifying its…
For decades, scientists have been studying the human reproductive system in order to better understand it and develop treatments for various reproductive conditions. Despite this, the ovaries – the organs responsible for producing and releasing eggs in women – have remained surprisingly understudied. Researchers have long sought to create in vitro models of human ovaries, which would allow for more in-depth study…
Wawa Fertility, a start-up founded in Denmark in late 2020, has expanded into the UK to support women undergoing fertility treatment. The Wawa app is a support system for fertility patients, designed as a personal assistant, that works to provide the most comprehensive treatment, including medical and mental health support. Goal is to provide healthcare that is personalized to each fertility patient’s…
Weill Cornell Medicine investigators have developed an experimental contraceptive drug candidate that temporarily immobilizes sperm, preventing pregnancies in preclinical models. The findings, published in Nature yesterday, suggest that an on-demand male contraceptive is possible. According to Dr. Jochen Buck and Dr. Lonny Levin, co-senior authors of the study and professors of pharmacology at Weill Cornell Medicine, this discovery could revolutionize contraception. Condoms…
Natural Cycles, a women’s health company known for its basal temperature based birth control app, has received funding from Samsung Ventures to intensify its AI/ML efforts and hardware development. The $7 million investment round also included contributions from all of Natural Cycles’ existing institutional investors Heartcore Capital, Headline, Bonnier Ventures and EQT Ventures. The FDA-cleared NC° app determines fertile and non-fertile days…
Twentyeight Health, a telehealth company providing affordable access and convenience for reproductive and sexual health, today announced that it has raised $8.3 million in Pre-Series A funding. The round included multiple mission-driven funds: RH Capital, Seae Ventures, Impact Engine, Acumen America, Stardust Equity, Gratitude Railroad, California Health Care Foundation, Penn Medicine-Wharton Fund for Health, and Great Oaks Venture Capital, and strategic angel…
Doveras, a New York-based fertility startup, is launching Pre-Pregnancy Clean Up, its first digital product today. The new program is focused on evidence-based lifestyle interventions to enhance male and female fertility potential, reduce time to pregnancy, and improve assisted reproductive outcomes. The new program may be Doveras’ first digital product on the market, Founder & CEO Nara Lee, however, is no stranger…
